title: Temporal summation of pressure pain during muscle hyperalgesia evoked by nerve growth factor and eccentric contractions.
abstract: Nerve growth factor (NGF) has a key role in the generation and potentiation of pain. Its centrally sensitizing effects may facilitate pain responses to noxious stimulus. This study assessed (1) the influence of NGF on delayed onset muscle soreness (DOMS) in shoulder muscles; and (2) the temporal summation of pressure pain during hyperalgesia induced by NGF and DOMS. In a blinded design, 10 healthy subjects were injected with NGF in the trapezius muscle on one side and with isotonic saline on the contralateral side as control. The subjects undertook shoulder eccentric exercise to induce DOMS in the shoulder muscles 3h after the injections. The soreness intensity to muscle contraction, pressure pain thresholds (PPT), and pain intensity to sequential stimuli (i.e. temporal summation at 1 and 30s inter-stimulus interval (ISI)) were assessed before injections - 3, 24h, and 4, 7, and 21 days after injections. The soreness intensity to muscle contraction significantly increased at 3 and 24h in both shoulders (P<0.05) and went back to baseline levels at day 7. The same development was seen in PPT as reduced thresholds (P<0.05). The NGF injected side had higher pain ratings during temporal summation at 1s ISI compared with the contralateral side 24h after injections. Intramuscular administration of NGF intensified the DOMS responses, evoking facilitated temporal summation. Central as well as peripheral sensitization mechanisms may play a role in the facilitation.
authors: Center for Sensory-Motor Interaction, Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 7D-3, DK-9220 Aalborg, Denmark.
authors: Hongling
authors: H
authors: Nie
authors: Pascal
authors: P
authors: Madeleine
authors: Lars
authors: L
authors: Arendt-Nielsen
authors: Thomas
authors: T
authors: Graven-Nielsen
mesh_terms: D000328:Adult; D015444:Exercise / Q000502:physiology; D006801:Humans; D006930:Hyperalgesia / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009135:Muscular Diseases / Q000139:chemically induced / Q000209:etiology*; D020932:Nerve Growth Factor / Q000494:pharmacology*; D010147:Pain Measurement / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects; D011312:Pressure; D055815:Young Adult
chemical_list: D020932:Nerve Growth Factor